rAAV-kallistatin gene therapy (Huaqiao University)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NamerAAV-kallistatin gene therapy (Huaqiao University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHuaqiao University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuaqiao University
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A